Genomics BioSci & Tech. Co.,Ltd. (TPE:4195)
11.70
-1.15 (-8.95%)
At close: Nov 20, 2026
Genomics BioSci & Tech. Market Cap
Genomics BioSci & Tech. has a market cap or net worth of 936 million as of November 20, 2026. It is the 33,762nd most valuable company in the world and the 2,001st biggest in Taiwan. Its market cap has decreased by 48.32% in one year.
Market Cap
936.00M
Enterprise Value
1.43B
Revenue
740.73M
Global Rank
Country Rank
#2,001 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 16, 2013, Genomics BioSci & Tech.'s market cap has decreased from 1.58B to 936.00M, a decrease of -40.80%. That is a compound annual growth rate of -3.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 936.00M | -49.73% |
| Dec 31, 2025 | 1.86B | 33.85% |
| Dec 31, 2024 | 1.39B | -7.69% |
| Dec 29, 2023 | 1.51B | 19.84% |
| Dec 30, 2022 | 1.26B | 11.67% |
| Dec 30, 2021 | 1.13B | 0.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 13.61B |
| Elixiron Immunotherapeutics (Cayman) Limited | 11.41B |
| Intelligene | 7.08B |
| Obigen Pharma | 6.22B |
| Uwell Biopharma | 4.92B |
| Tripartite Therapeutics | 3.31B |
| Pet Pharm Biotech | 2.40B |
| BIONET Therapeutics | 2.07B |